Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Developed by the Australian company Clinuvel Pharmaceuticals under the commercial name Scenesse , afamelanotide received EMA approval in 2014 and FDA approval in 2019 for the prevention of phototoxicity in patients with erythropoietic protoporphyria (EPP), a rare orphan disease
Enter reconstitution details Select the bacteriostatic water volume used to reconstitute your vial
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
microbiota-derived modulation The regulation of energy balance reflects coordinated interactions between peripheral nutrient sensing and central neural integration
Regular exercise, including strength training, can help you hold onto more of that lean muscle masswhich can improve your metabolic rate and help with body composition and fat loss
2007 Sept;282, 27155-27164
US$ 23.77
US$ 28.88
US$ 26.02
US$ 29.28
US$ 26.74
US$ 23.69
